Düsseldorf Clinics Association
- Hosts over 200,000 patients annually, providing extensive experience in patient care, including Immunotherapy.
- Features 60 top-rated professors who lead medical research and contribute to the development of Immunotherapy protocols.
- Houses a specialized Oncology Department where Immunotherapy is a primary treatment for various malignancies.
- Utilizes Immunostimulating drugs and Targeted medication in Immunotherapy, focusing on precision and minimizing side effects.
- Conducts interdisciplinary oncology conferences to tailor the most effective Immunotherapy plans for complex cases.